Alvotech
ALVOW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVO
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 7
- 13F valueReported value at the end of Q2 2026
- $1.16M
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Superinvestors holding ALVOW, Q2 2026
1 superinvestor reports holding Alvotech on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
Open-market purchases and sales by Alvotech insiders from Form 4, newest first.
No open-market purchases or sales by Alvotech insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Alvotech at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 4,666,667 | $1.07M | 0.02% | 00.0% | Unchanged |
| Linden Advisors LP | 252,884 | $51.9K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 56,252 | $12.9K | 0.00% | 00.0% | Unchanged |
| Moore Capital Management, LP | 50,000 | $11.5K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 24,165 | $5.56K | 0.00% | +24,165 | New |
| Sculptor Capital LP | 3,702 | $851 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,155 | $266 | 0.00% | +782+209.7% | Added |